Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Stockholm-based Eyedentity secures €1.3 million to enhance its AI-powered diagnostics platform for early detection of eye cancer. The round was led by Norrsken Launcher, with support from Karolinska Institutet Innovation and angel investors.
Stockholm-based MedTech startup Eyedentity has closed its first oversubscribed investment round of €1.3 million (SEK 15 million). The funding will support regulatory approval, product development, and expansion into opticians, eye clinics, and hospitals. The round was led by Norrsken Launcher and included participation from Karolinska Institutet Innovation and a group of angel investors. This investment underscores the growing interest in AI-driven diagnostics in the European medical sector.
Company Information
Company
Eyedentity
Location
Sweden
About
Eyedentity is a MedTech startup focused on developing AI technology for early detection of serious eye diseases from routine fundus images. The company's first application targets uveal melanoma, a rare and potentially deadly eye cancer. By leveraging existing technologies used during routine eye examinations, Eyedentity aims to reduce false-positive referrals and improve patient outcomes. Founded in 2025, the company is part of the Karolinska Institutet Innovation Incubator.
Don't miss Eyedentity's next move
Get an email the moment Eyedentity raises, hires an exec, or expands, usually minutes after it happens.
SwedenBiotechnologyHealth CareArtificial Intelligence